CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 899 enrolled
Drug / intervention
Pioglitazonedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02003014
NCT02003014N/ACompleted
CompareCT.gov

Actos Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment"

Takeda·observational·Posted Dec 6, 2013·Updated Nov 10, 2016

In Brief

An observational study evaluating Pioglitazone for Type 2 Diabetes Mellitus. Completed, enrolled 899 participants.

Detailed Summary

To investigate the safety and efficacy of long-term treatment with pioglitazone (Actos tablets) in combination with biguanides (for 12 months after the start of pioglitazone tablets treatment) in patients with type 2 diabetes mellitus.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Mellitus
Countries--
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 6, 2013
Enrollment StartFeb 1, 2009
Primary CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 12.6 years ago

Interventions

Pioglitazonedrug

Pioglitazone Tablets